Healthcare Providers and Services
Company Overview of Geisinger Health System
Geisinger Health System offers healthcare services. The company owns and operates medical centers, outpatient clinics, hospitals, health research centers, and children’s and rehabilitation hospitals. It focuses on cancer treatment, heart services, neurosciences, orthopaedics, pediatrics, transplants, and women's health. The company also develops and implements healthcare models including ProvenHealth Navigator and ProvenCare. Additionally, it offers research and clinical trial, blood conservation, outpatient surgery, and care management services. Geisinger Health System was formerly known as George F. Geisinger Memorial Hospital. The company was founded in 1915 and is based in Danville, Penn...
100 North Academy Avenue
Danville, PA 17822-4910
Founded in 1915
Key Executives for Geisinger Health System
President and Chief Executive Officer
Executive Vice President of Finance and Chief Financial Officer
Executive Vice President and Chief Operating Officer
Executive Vice President and Chief Scientific Officer
Executive Vice President of Insurance Operations
Compensation as of Fiscal Year 2013.
Geisinger Health System Key Developments
Regeneron Pharmaceuticals, Inc. and Geisinger Health System Announce Major Research Collaboration
Jan 13 14
Regeneron Pharmaceuticals, Inc. and Geisinger Health System announced a major research collaboration focused on studying the genetic determinants of human disease. During the initial five-year collaboration term, Geisinger plans to collect samples from more than 100,000 consented patient volunteers, while Regeneron, through its wholly-owned subsidiary, Regeneron Genetics Center LLC, will perform sequencing and genotyping to generate de-identified genomic data. The size and scope of the study are meant to allow great precision in identifying and validating the associations between genes and human disease.
Geisinger Health System Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-13-2014 01:30 PM
Dec 31 13
Geisinger Health System Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-13-2014 01:30 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Glenn D. Steele, President and Chief Executive Officer, Kevin F. Brennan, Executive Vice President of Finance and Chief Financial Officer.
Geisinger Health System Partners with Indivumed for Personalized Medicine Initiative
May 10 13
Geisinger Health System announced plans to partner with Indivumed, a relationship that will afford Geisinger patients access to advanced cancer treatment and clinical trials. The collaboration will allow Indivumed staff to collect tissue, blood and urine from consenting Geisinger patients who are already undergoing a surgical tumor resection. Upon resection, a portion of the tissue, blood or urine remaining beyond what is required to make a clinical diagnosis will be banked by Geisinger through MyCode(TM), a repository that currently holds 43,000 patient samples. Another portion will be banked by Indivumed, which will analyze the tissue to determine its molecular and biochemical profile. That information will be used in the development and, eventually, application of targeted therapies for cancer patients. The overall goal is understanding the biological differences between tumors and how patients respond to treatments to support the implementation of personalized therapy. To this end, Indivumed maintains a biobank of tissues and annotated data from about 17,000 patients - with about 1,500 new cases added per year - each collected under exactly defined specifications.
Similar Private Companies By Industry
Recent Private Companies Transactions